Help | RSS Feed

Acura Pharmaceuticals, Inc. (OTCMKT:ACUR) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Acura Pharmaceuticals, Inc. (OTCMKT:ACUR) seasonal charts above shows that a Buy Date of January 7 and a Sell Date of April 21 has resulted in a geometric average return of 21.23% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 17 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 50.44% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Acura Pharmaceuticals Inc is a specialty pharmaceutical company based in the United States. It is engaged in the research, development, and commercialization of technologies and products intended to address medication abuse and misuse. The company has developed Aversion and Limitx technologies are intended to address methods of abuse associated with opioid analgesics whereas Impede technology is directed at minimizing the extraction and conversion of pseudoephedrine (PSE), into methamphetamine. Its product line includes OXAYDO which is a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and other pipeline products.

To download ACUR seasonal chart data, please log in or Subscribe.


Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Sponsored By...
Seasonal Advantage Portfolio by CastleMoore